What does Tevogen Bio Holdings Inc. do?
Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19…
What is Tevogen Bio Holdings Inc.'s P/E and P/B ratio?
Tevogen Bio Holdings Inc. has a P/E ratio of -1.0 and a P/B ratio of -4.99.
What is Tevogen Bio Holdings Inc.'s debt-to-equity ratio?
Tevogen Bio Holdings Inc. has a debt-to-equity ratio of -0.91.
How much does Tevogen Bio Holdings Inc. owe compared with what it owns?
Tevogen Bio Holdings Inc. owes $2.88 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Tevogen Bio Holdings Inc.'s Positivity rank?
Tevogen Bio Holdings Inc. is ranked #6,431 of 6,774 companies globally and #3,694 of 4,000 in United States on PositoAI, with a Positivity Score of -19,346.
Does Tevogen Bio Holdings Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Tevogen Bio Holdings Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 22 Apr 2026). It has no yellow flags.
Where can I read the latest news about Tevogen Bio Holdings Inc.?
Recent headlines about Tevogen Bio Holdings Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Tevogen Bio Holdings Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Tevogen Bio Holdings Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.